scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1018555920 |
P356 | DOI | 10.1186/1471-2407-7-11 |
P8608 | Fatcat ID | release_fftyzg3vf5c2pgatbce2p6bswu |
P932 | PMC publication ID | 1781459 |
P698 | PubMed publication ID | 17233882 |
P5875 | ResearchGate publication ID | 6568644 |
P50 | author | Heidi Lyng | Q17102603 |
Beathe Sitter | Q55487435 | ||
Tone F. Bathen | Q61104171 | ||
Ingrid Susann Gribbestad | Q65706743 | ||
P2093 | author name string | Gunnar B Kristensen | |
Kolbein Sundfør | |||
Line R Jensen | |||
P2860 | cites work | Phospholipase D in cell proliferation and cancer | Q28205631 |
Classification of human liposarcoma and lipoma using ex vivo proton NMR spectroscopy | Q57102825 | ||
Quantitative analysis of apoptotic cell death using proton nuclear magnetic resonance spectroscopy | Q58479919 | ||
1H MRS of high grade astrocytomas: mobile lipid accumulation in necrotic tissue | Q72175300 | ||
Changes in tumor oxygen tension during radiotherapy of uterine cervical cancer: relationships to changes in vascular density, cell density, and frequency of mitosis and apoptosis | Q73515970 | ||
High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human cervical cancers | Q73519226 | ||
Expression of cIAP1, a target for 11q22 amplification, correlates with resistance of cervical cancers to radiotherapy | Q28220281 | ||
1H NMR visible lipids in the life and death of cells | Q30604603 | ||
Metabolite changes in BT4C rat gliomas undergoing ganciclovir-thymidine kinase gene therapy-induced programmed cell death as studied by 1H NMR spectroscopy in vivo, ex vivo, and in vitro. | Q30822802 | ||
Tumour phospholipid metabolism | Q33179622 | ||
The biochemistry of living tissues: examination by MRS | Q33193056 | ||
Apoptosis and therapy | Q33643364 | ||
Apoptosis in cancer | Q33846227 | ||
Choline phospholipid metabolism: a target in cancer cells? | Q35549481 | ||
Lactate: mirror and motor of tumor malignancy | Q35837050 | ||
Pathways of apoptotic and non-apoptotic death in tumour cells | Q35852309 | ||
Quantitative neuropathology by high resolution magic angle spinning proton magnetic resonance spectroscopy | Q36185748 | ||
Host defense--a role for the amino acid taurine? | Q41686313 | ||
Assignment of 1H nuclear magnetic resonance visible polyunsaturated fatty acids in BT4C gliomas undergoing ganciclovir-thymidine kinase gene therapy-induced programmed cell death | Q44480744 | ||
Proton HR‐MAS spectroscopy and quantitative pathologic analysis of MRI/3D‐MRSI‐targeted postsurgical prostate tissues | Q44637716 | ||
Cervical cancer tissue characterized by high-resolution magic angle spinning MR spectroscopy | Q44785789 | ||
Preinvasive and invasive cervical cancer: an ex vivo proton magic angle spinning magnetic resonance spectroscopy study | Q44891525 | ||
Hypoxic cervical cancers with low apoptotic index are highly aggressive. | Q45128481 | ||
High-resolution magic angle spinning 1H NMR spectroscopy and reverse transcription-PCR analysis of apoptosis in a rat glioma | Q45856336 | ||
1H MRS detects polyunsaturated fatty acid accumulation during gene therapy of glioma: implications for the in vivo detection of apoptosis. | Q45863255 | ||
High-resolution magic-angle-spinning 1H NMR spectroscopy reveals different responses in choline-containing metabolites upon gene therapy-induced programmed cell death in rat brain glioma. | Q45883454 | ||
Comparison of HR MAS MR spectroscopic profiles of breast cancer tissue with clinical parameters | Q46756319 | ||
Quantitative analysis of prostate metabolites using 1H HR-MAS spectroscopy | Q46843127 | ||
P275 | copyright license | Creative Commons Attribution 2.0 Generic | Q19125117 |
P6216 | copyright status | copyrighted | Q50423863 |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 11 | |
P577 | publication date | 2007-01-17 | |
P1433 | published in | BMC Cancer | Q326300 |
P1476 | title | Metabolic mapping by use of high-resolution magic angle spinning 1H MR spectroscopy for assessment of apoptosis in cervical carcinomas | |
P478 | volume | 7 |
Q48338205 | Applications of high-resolution magic angle spinning MRS in biomedical studies II-Human diseases. |
Q37177549 | Clinical applications of metabolomics in oncology: a review |
Q34684585 | Feasibility of MR metabolomics for immediate analysis of resection margins during breast cancer surgery |
Q33408011 | High resolution magic angle spinning 1H NMR of childhood brain and nervous system tumours |
Q36581517 | Isotope enhanced approaches in metabolomics |
Q33888362 | MR-visible lipids and the tumor microenvironment |
Q33748176 | Merging transcriptomics and metabolomics--advances in breast cancer profiling |
Q37074142 | Metabolomics in biomarker discovery: future uses for cancer prevention |
Q37867682 | Metabolomics in urogenital cancer |
Q37266489 | Metabolomics-based methods for early disease diagnostics |
Q37462435 | Metabolomics: moving to the clinic |
Q34041364 | Monitoring the Effect of Docetaxel Treatment in MCF7 Xenografts Using Multimodal In Vivo and Ex Vivo Magnetic Resonance Methods, Histopathology, and Gene Expression |
Q43227553 | Multivariate modeling and prediction of breast cancer prognostic factors using MR metabolomics |
Q34234941 | Pharmaco-metabolomics: an emerging "omics" tool for the personalization of anticancer treatments and identification of new valuable therapeutic targets |
Q36649292 | Principal component analysis for the comparison of metabolic profiles from human rectal cancer biopsies and colorectal xenografts using high-resolution magic angle spinning 1H magnetic resonance spectroscopy |
Q43165528 | Taurine: a potential marker of apoptosis in gliomas. |
Q39032724 | The Tumor Microenvironment Modulates Choline and Lipid Metabolism |
Q37512764 | The future of NMR metabolomics in cancer therapy: towards personalizing treatment and developing targeted drugs? |
Q37374479 | Use of nuclear magnetic resonance-based metabolomics in detecting drug resistance in cancer |
Search more.